Suppr超能文献

带或不带引导微导丝的Tenzing 7输送导管用于单次通过抽吸血栓切除术:多中心经验。

Tenzing 7 delivery catheter with or without a leading microwire for single pass aspiration thrombectomy: A multicenter experience.

作者信息

Tonetti Daniel A, Koneru Manisha, Bhattacharyya Meghna, English Joey D, Settecase Fabio, Kim Warren T, Khalife Jane, Patel Pratit, Thomas Ajith, Jovin Tudor, Hanel Ricardo, Benalia Victor H C, Cortez Gustavo M, Aghaebrahim Amin, Sauvageau Eric, Abdalkader Mohamad, Nguyen Thanh N, Klein Piers, Dmytriw Adam A, Shaikh Hamza

机构信息

Cooper University Health Care, Camden, NJ, USA.

Cooper Medical School of Rowan University, Camden, NJ, USA.

出版信息

Interv Neuroradiol. 2023 Nov 28:15910199231216765. doi: 10.1177/15910199231216765.

Abstract

INTRODUCTION

Aspiration mechanical thrombectomy traditionally includes use of an inner microcatheter and leading microwire to navigate an aspiration catheter (AC) to the site of occlusion. Early clinical experience suggests that a leading microwire is often not needed with the Tenzing 7 (T7, Route 92 Medical, San Mateo, CA), a soft tapered tip ledge-reducing delivery catheter. This multicenter experience aims to describe AC delivery success in single-pass thrombectomy using T7 with and without a leading microwire.

METHODS

A retrospective review was conducted of consecutive patients who underwent single-pass thrombectomy with T7 at six institutions between 2020 and 2022. We examined the percentage of successful AC delivery, puncture-to-revascularization time, and procedural complication rate.

RESULTS

A leading microwire with T7 was used in 19/89 (21%) of patients, and it was not used with T7 in 70/89 (79%) of patients. Successful AC delivery was similar with and without microwires (97% vs. 90%, p = 0.15). Median puncture-to-revascularization times were similar (17 min microwire vs. 16 min no-microwire, p = 0.12). No complications were associated with microwire use; one (1.4%) patient had a T7-related vasospasm resolved with verapamil during thrombectomy without a leading microwire. Differences in complication rates were not statistically significant (p = 0.46).

CONCLUSION

In our real-world clinical experience, leading microwire use was infrequently necessary with the T7 delivery catheter. Successful AC delivery and complication rates were similar with and without microwire use in single-pass T7 thrombectomies. Initial pass with T7 may be performed without use of leading microwire, reserving microwire use for refractory cases or known difficult-to-navigate vasculature.

摘要

引言

传统的抽吸式机械血栓切除术包括使用内部微导管和引导微丝将抽吸导管(AC)导航至闭塞部位。早期临床经验表明,对于Tenzing 7(T7,Route 92 Medical,加利福尼亚州圣马特奥)这种软锥形尖端减少壁架的输送导管,通常不需要引导微丝。这项多中心研究旨在描述在使用T7进行单通道血栓切除术时,有无引导微丝情况下AC输送的成功率。

方法

对2020年至2022年间在六个机构接受T7单通道血栓切除术的连续患者进行回顾性研究。我们检查了AC输送成功的百分比、穿刺至再通时间和手术并发症发生率。

结果

89例患者中有19例(21%)在使用T7时使用了引导微丝,70例(79%)患者在使用T7时未使用引导微丝。有无微丝时AC输送成功的比例相似(97%对90%,p = 0.15)。穿刺至再通的中位时间相似(使用微丝为17分钟,未使用微丝为16分钟,p = 0.12)。使用微丝未出现并发症;1例(1.4%)患者在无引导微丝的血栓切除术中出现T7相关的血管痉挛,使用维拉帕米后缓解。并发症发生率的差异无统计学意义(p = 0.46)。

结论

在我们的实际临床经验中,使用T7输送导管时很少需要引导微丝。在T7单通道血栓切除术中,有无微丝时AC输送成功和并发症发生率相似。T7的首次操作可以在不使用引导微丝的情况下进行,将微丝的使用保留用于难治性病例或已知难以导航的血管系统。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验